This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2014 Apr;15(4):372-4.

doi: 10.1016/S1470-2045(14)70070-1. Epub 2014 Feb 24.

Radiotherapy for indolent lymphomas: how much is enough?

Affiliations

Affiliation

¹ Department of Oncology and Haematology, Rigshospitalet, University of Copenhagen, Blegdamsvej 9, 2100 Copenhagen, Denmark. Electronic address: lena.specht@regionh.dk.

PMID: 24572076
DOI: 10.1016/S1470-2045(14)70070-1

Comment

Radiotherapy for indolent lymphomas: how much is enough?

Lena Specht. Lancet Oncol. 2014 Apr.

. 2014 Apr;15(4):372-4.

doi: 10.1016/S1470-2045(14)70070-1. Epub 2014 Feb 24.

Author

Affiliation

¹ Department of Oncology and Haematology, Rigshospitalet, University of Copenhagen, Blegdamsvej 9, 2100 Copenhagen, Denmark. Electronic address: lena.specht@regionh.dk.

PMID: 24572076
DOI: 10.1016/S1470-2045(14)70070-1

No abstract available

PubMed Disclaimer

Comment on

4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 non-inferiority trial.
Hoskin PJ, Kirkwood AA, Popova B, Smith P, Robinson M, Gallop-Evans E, Coltart S, Illidge T, Madhavan K, Brammer C, Diez P, Jack A, Syndikus I. Hoskin PJ, et al. Lancet Oncol. 2014 Apr;15(4):457-63. doi: 10.1016/S1470-2045(14)70036-1. Epub 2014 Feb 24. Lancet Oncol. 2014. PMID: 24572077 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations